Watch Ticker

Merus N.V. Common Shares

Go to Merus N.V. Common Shares Website

$67.45

0.00 (0.00%)

Live

Previous Close

$67.45

Day Range

$0 - $0

Previous Day Range

$66.02 - $67.47

Market Cap

$5.0 billion USD

Day Vol.

Previous Day Vol.

557324

Currency

USD

Primary Exchange

Nasdaq

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment compr...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Globe Newswire - Merus N.V. Announces Proposed Public Offering of Common Shares

Merus N.V., an oncology company, announced a proposed underwritten public offering of its common shares. The company plans to use the net proceeds to advance the clinical development of its product candidates, for preclinical research and technology development, and for working capital and general corporate purposes.

Related tickers: MRUS.

Read Full Article

N/A - Les données intermédiaires du pétosemtamab de Merus en association avec le pembrolizumab démontrent une réelle efficacité et une bonne durabilité dans le traitement de 1re ligne contre le CETC r/m PD-L1+

Merus' petosemtamab in combination with pembrolizumab showed a 63% response rate and 79% overall survival rate at 12 months in the treatment of first-line PD-L1+ recurrent/metastatic head and neck squamous cell carcinoma.

Related tickers: MRUS.

Read Full Article

Trending Tickers

Please sign in to view